ストックスクリーナーアプリを入手
18.91
2.53%
0.35
Relay Therapeutics Inc (RLAY) 最新ニュース
Relay Therapeutics, Inc.(NasdaqGM: RLAY) added to Russell 2000 Growth Benchmark - marketscreener.com
Relay Therapeutics, Inc.(NasdaqGM: RLAY) added to Russell 3000E Growth Benchmark - marketscreener.com
Why Is RLAY Stock Rising Today? - Stocktwits
RLAY stock declines pre-market after $175M offering — despite fresh bullish calls on Relay's zovegalisib - MSN
Relay Therapeutics, Inc. Actuals & Estimates (NASDAQ:RLAY) - TradingView
RLAY Forecast — Price Target — Prediction for 2027 - TradingView
Relay Therapeutics Stock Rockets 34% With 9-Day Winning Streak - Trefis
Relay Therapeutics (RLAY) Short Interest & Short Float | Updated Jun 2026 $RLAY - MarketBeat
Relay Therapeutics (RLAY) Stock Analysis Report | Ratings, Financials & Performance - Benzinga España
Form 4 Relay Therapeutics Inc For: 24 June By Investing.com - Investing.com Nigeria
Relay Therapeutics president R&D sells $1.58m in stock By Investing.com - Investing.com Nigeria
Relay Therapeutics president R&D sells $1.58m in stock - Investing.com
Relay Therapeutics (RLAY) R&D chief exercises options and sells 93K shares - Stock Titan
Relay Therapeutics (NASDAQ: RLAY) CFO sells 187,163 shares after exercising options - Stock Titan
8-Day Rally Sends Relay Therapeutics Stock Up 29% - Trefis
Relay Therapeutics stock hits 52-week high at 17.54 USD - Investing.com UK
Relay Therapeutics stock hits 52-week high at 17.54 USD By Investing.com - Investing.com South Africa
Form 144 RELAY THERAPEUTICS For: 22 June By Investing.com - Investing.com Australia
Form 144 | Relay Therapeutics(RLAY.US) Officer Proposes to Sell 3.25 Million in Common Stocks - Moomoo
Donald A. (RLAY) files Form 144 to sell 93,456 shares on 06/22/2026 - Stock Titan
RLAY: Director Thomas Catinazzo executed 4 10b5-1 sales (Apr–May 2026) - Stock Titan
Relay Therapeutics StockAnalyst views and long-term strategy in focus - Ad-hoc-news.de
Analysts Are Bullish on These Healthcare Stocks: BrightSpring Health Services, Inc. (BTSG), Relay Therapeutics (RLAY) - The Globe and Mail
Top Smidcap Pick: TD Cowen Highlights Relay Therapeutics By Investing.com - Investing.com South Africa
Relay Therapeutics Inc (RLAY) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Relay Therapeutics Inc (RLAY) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Relay Therapeutics Inc (RLAY) Institutional Confidence - TradingKey
Relay Therapeutics Inc (RLAY) Valuation: PE, PB & Fair Value Analysis - TradingKey
Relay Therapeutics Inc (RLAY) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Relay Therapeutics Inc (RLAY) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Relay Therapeutics Inc (RLAY) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Relay Therapeutics Inc (RLAY) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Relay Therapeutics Q1 2026 earnings preview - MSN
Number of shareholders of Relay Therapeutics, Inc. – NASDAQ:RLAY - TradingView
Relay Therapeutics (RLAY) is One of the Best AI Driven Biotech Stocks, Here is Why - Insider Monkey
Relay Therapeutics Expands Authorized Shares at 2026 Meeting - The Globe and Mail
[Form 4] Relay Therapeutics, Inc. Insider Trading Activity - Stock Titan
Relay Therapeutics (RLAY) director granted options on 32,947 shares at $14.09 - Stock Titan
10 Best AI Driven Biotech Stocks to Invest In - Insider Monkey
Relay Therapeutics (NASDAQ: RLAY) ups authorized common stock to 450M - Stock Titan
Relay Therapeutics prices $275M public offering of common stock at $12/share - MSN
RLAY News | RELAY THERAPEUTICS INC (NASDAQ:RLAY) - ChartMill
Analysts Offer Insights on Healthcare Companies: Replimune Group (REPL), Eli Lilly & Co (LLY) and Relay Therapeutics (RLAY) - The Globe and Mail
RLAY stock lights up on vascular anomalies treatment data boost – 60% of patients show sharp reduction in lesion volume - MSN
0.46%
0.50%
大文字化:
|
ボリューム (24 時間):